V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006611 | 10004437 | 1.82 | 86 | Palliative (P) | 2016-03-29 | 2016-03-30 | Capecitabine | 1 | N | 10442658 | CAPECITABINE |
| 10006612 | 10004439 | 1.72 | null | Palliative (P) | 2016-03-05 | 2016-03-05 | Capecitabine | N | N | 10442940 | CAPECITABINE |
| 10006613 | 10004440 | 1.69 | 84 | Palliative (P) | 2018-01-11 | 2018-01-11 | Bevacizumab 7.5mg/kg | 2 | N | 10443025 | LENALIDOMIDE |
| 10006614 | 10004440 | 1.72 | null | Palliative (P) | 2017-01-11 | 2017-01-11 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10443025 | CVP R |
| 10006615 | 10004440 | 1.8 | 75 | null | 2018-09-27 | 2018-10-04 | Azacitidine | N | N | 10443025 | AZACITIDINE |
| 10006616 | 10004445 | 1.65 | null | Curative (C) | 2017-06-17 | 2017-07-02 | GEMCITABINE | N | N | 10443855 | FLUOROURACIL |
| 10006617 | 10004449 | 1.55 | 94 | Adjuvant (A) | 2014-04-10 | 2014-04-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 10443855 | CARBOPLATIN + PACLITAXEL |
| 10006618 | 10004450 | null | 91.3 | Palliative (P) | 2018-11-11 | 2018-12-09 | GEMCARBO | N | N | 10444120 | LENALIDOMIDE |
| 10006619 | 10004451 | 1.74 | 86 | Disease modification (D) | 2016-12-04 | 2016-12-18 | Trial Unspecified | 2 | null | 10444120 | TRIAL |
| 10006620 | 10004451 | null | 85.3 | Adjuvant (A) | 2014-11-14 | 2014-11-15 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 10444120 | PEMETREXED |
| 10006621 | 10004451 | 1.7 | 108.9 | Palliative (P) | 2018-12-22 | 2018-12-25 | Azacitidine | Y | N | 10444120 | AZACITIDINE |
| 10006622 | 10004452 | 1.76 | 103.5 | Palliative (P) | 2015-01-31 | 2015-03-01 | CARBOPLATIN + VINORELBINE | 02 | N | 10444435 | ABIRATERONE |
| 10006623 | 10004452 | 1.95 | 71.4 | Adjuvant (A) | null | 2017-03-15 | Capecitabine | N | N | 10444435 | CAPECITABINE |
| 10006624 | 10004452 | 1.65 | 82 | Palliative (P) | 2018-04-15 | 2018-04-18 | Abiraterone | 02 | N | 10444435 | NOT MATCHED |
| 10006625 | 10004453 | 1.67 | 70.3 | Disease modification (D) | 2016-03-18 | 2017-11-11 | CARBOPLATIN + VINORELBINE | N | N | 10444538 | BEVACIZUMAB |
| 10006626 | 10004453 | 1.8 | 70.2 | Palliative (P) | 2016-05-31 | 2016-06-22 | BENDAMUSTINE + RITUXIMAB | N | N | 10444538 | BENDAMUSTINE + RITUXIMAB |
| 10006627 | 10004454 | 1.72 | 79.1 | Curative (C) | 2018-03-19 | 2018-03-28 | GemCarbo Days 1+8 | 02 | N | 10445051 | CARBOPLATIN + VINORELBINE |
| 10006628 | 10004455 | 1.87 | 88.9 | Palliative (P) | 2018-05-07 | 2018-05-07 | Abiraterone | 02 | N | 10445101 | CARBOPLATIN + PEMETREXED |
| 10006629 | 10007288 | 1.7 | 67.9 | Not known (9) | 2017-10-15 | 2017-10-20 | Trial Unspecified | N | N | 10445140 | TRIAL |
| 10006630 | 10007289 | 1.79 | null | Palliative (P) | 2017-03-24 | 2017-05-24 | GEMCITABINE | N | N | 10445208 | CARBOPLATIN + VINORELBINE |
| 10006631 | 10004459 | 1.72 | 75.1 | Adjuvant (A) | 2018-02-17 | 2018-02-22 | Capecitabine | N | Y | 10445619 | CAPECITABINE |
| 10006632 | 10004460 | 1.63 | 75.1 | Palliative (P) | 2013-06-18 | 2013-06-19 | Carboplatin + Pemetrexed | 02 | N | 10445619 | CARBOPLATIN |
| 10006633 | 10004461 | 1.73 | 108.4 | Palliative (P) | 2018-03-16 | 2018-03-21 | Capecitabine | N | N | 10445721 | CAPECITABINE |
| 10006634 | 10004464 | 1.44 | 59 | Disease modification (D) | 2017-11-19 | 2018-12-13 | Carboplatin + Vinorelbine Oral | N | N | 10445974 | LENALIDOMIDE |
| 10006635 | 10004466 | 1.74 | null | Curative (C) | 2017-01-14 | 2017-06-06 | Carboplatin + Etoposide iv&po | null | Y | 10446319 | CARBOPLATIN + ETOPOSIDE |
| 10006636 | 10007293 | 1.66 | 64 | Curative (C) | 2014-10-30 | 2014-11-25 | null | N | null | 10446829 | IBRUTINIB |
| 10006637 | 10004469 | 1.8 | 84 | Curative (C) | 2017-04-17 | 2017-04-17 | Bevacizumab | N | N | 10446829 | GEMCARBO |
| 10006638 | 10004470 | 1.65 | 92 | Disease modification (D) | 2018-10-16 | 2019-01-20 | CARBOPLATIN | null | N | 10447679 | NOT MATCHED |
| 10006639 | 10004471 | 1.72 | 75.8 | Disease modification (D) | 2015-07-18 | 2015-08-16 | IBRUTINIB | N | null | 10447723 | GEMCARBO |
| 10006640 | 10004471 | 1.8 | 93.8 | Neo-adjuvant (N) | 2015-08-29 | 2015-09-21 | null | N | N | 10447723 | FLUOROURACIL |
| 10006641 | 10004471 | 1.82 | 67 | Palliative (P) | 2016-04-27 | 2016-04-27 | Carboplatin + Pemetrexed | N | Y | 10447723 | NOT MATCHED |
| 10006642 | 10004476 | 1.71 | 73.2 | Curative (C) | 2015-04-21 | 2015-08-16 | Carboplatin + Paclitaxel (3 weekly) | null | N | 10448243 | CARBOPLATIN + PACLITAXEL |
| 10006643 | 10004478 | 1.73 | 57 | Disease modification (D) | 2018-05-08 | 2018-05-11 | Abiraterone | N | N | 10448323 | NOT MATCHED |
| 10006644 | 10004479 | 1.5 | 59.3 | Adjuvant (A) | null | 2018-02-02 | null | 02 | null | 10448482 | GEMCITABINE |
| 10006645 | 10004481 | 1.99 | null | Adjuvant (A) | 2017-11-13 | 2017-11-19 | FLUOROURACIL | 2 | N | 10448518 | NOT MATCHED |
| 10006646 | 10004483 | 0 | 81.9 | Palliative (P) | 2018-06-22 | 2018-08-24 | BCG Intravesical | 2 | Y | 10448599 | BCG |
| 10006647 | 10004484 | 1.7 | 62.6 | Adjuvant (A) | 2017-12-07 | 2018-03-12 | Temozolomide 150mg/m2 | 1 | Y | 10449193 | TEMOZOLOMIDE |
| 10006648 | 10004484 | null | 82 | Curative (C) | null | 2016-09-29 | Carboplatin + Etoposide iv&po | N | N | 10449193 | CARBOPLATIN + ETOPOSIDE |
| 10006649 | 10004485 | 1.73 | 93.1 | Adjuvant (A) | 2017-04-21 | 2017-05-01 | Capecitabine | null | Y | 10449649 | CAPECITABINE |
| 10006650 | 10004486 | 1.83 | 78 | null | 2018-08-10 | 2019-06-19 | IBRUTINIB | N | N | 10449668 | LENALIDOMIDE |
| 10006651 | 10004487 | 1.47 | null | Palliative (P) | 2018-03-07 | 2018-05-06 | Capecitabine | N | N | 10449839 | CAPECITABINE |
| 10006652 | 10004491 | 1.82 | 74 | Palliative (P) | null | 2018-03-27 | GEMCARBO | N | N | 10450022 | GEMCITABINE |
| 10006653 | 10004493 | 1.73 | 52.7 | Palliative (P) | 2018-08-14 | 2018-08-14 | TEMOZOLOMIDE | N | N | 10450024 | TEMOZOLOMIDE |
| 10006654 | 10007300 | 1.75 | 74 | Palliative (P) | 2017-10-17 | 2017-10-17 | Carboplatin + Etoposide iv&po | 02 | N | 10450045 | CARBOPLATIN + ETOPOSIDE |
| 10006655 | 10007300 | 1.61 | 56.4 | Disease modification (D) | 2013-08-19 | 2013-09-02 | IBRUTINIB | 02 | N | 10450045 | LENALIDOMIDE |
| 10006656 | 10007300 | 1.76 | 0 | Palliative (P) | 2018-03-05 | 2018-03-07 | Azacitidine | 2 | N | 10450045 | AZACITIDINE |
| 10006657 | 10004495 | 1.8 | 60 | Curative (C) | 2018-07-28 | 2018-09-30 | CVP R | 02 | N | 10450542 | ABIRATERONE |
| 10006658 | 10004496 | 1.8 | 91.4 | Curative (C) | 2016-02-21 | 2016-02-21 | Trial Unspecified | 2 | N | 10450677 | TRIAL |
| 10006659 | 10004498 | 1.74 | 97.8 | Palliative (P) | 2016-11-17 | 2016-11-23 | Carboplatin AUC 6 - 10 | N | null | 10450803 | CARBOPLATIN + PEMETREXED |
| 10006660 | 10007304 | 1.76 | 64 | Curative (C) | 2017-10-11 | 2017-10-11 | BENDAMUSTINE + RITUXIMAB | N | N | 10450858 | BENDAMUSTINE + RITUXIMAB |